Screening and confirmation methods of the major urinary metabolite of finasteride-carboxy-finasteride by liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry
Screening and confirmation methods of the major urinary metabolite of finasteride-carboxy-finasteride for doping control purpose were developed. Liquid-liquid extraction was adopted for the sample preparation. Analytes were detected by positive electrospray ionization in single quadrupole and triple...
Saved in:
Main Author: | Jianli Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2012-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquid Chromatography-Tandem Mass Spectrometry in Newborn Screening Laboratories
by: Michael H. Gelb, et al.
Published: (2022) -
Establishment to measure oxycodone in plasma with liquid chromatography-tandem mass spectrometry
by: Suguru Ito, et al.
Published: (2022) -
Applying liquid chromatography-tandem mass spectrometry to assess endodontic sealer microleakage
by: André Luiz da Costa MICHELOTTO, et al.
Published: (2015) -
Metabolic Stability Assessment of Larotrectinib Using Liquid Chromatography Tandem Mass Spectrometry
by: Attwa MW, et al.
Published: (2020) -
Determination of lamotrigine in human plasma using liquid chromatography‐tandem mass spectrometry
by: Shogo Itabashi, et al.
Published: (2019)